Storebrand Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,738
Closed -$69.3K 870
2022
Q4
$69.3K Sell
6,738
-2,945
-30% -$52K ﹤0.01% 806
2022
Q3
$176K Sell
9,683
-27,730
-74% -$1.2M ﹤0.01% 764
2022
Q2
$1.92M Buy
37,413
+860
+2% +$44.5K 0.01% 596
2022
Q1
$2.69M Buy
36,553
+3,492
+11% +$311K 0.01% 579
2021
Q4
$4.73M Buy
33,061
+3,534
+12% +$607K 0.02% 521
2021
Q3
$6.12M Buy
29,527
+2,348
+9% +$517K 0.03% 467
2021
Q2
$5.77M Buy
+27,179
New +$4.98M 0.03% 483

Other funds holding NVAX

Storebrand Asset Management's NVAX Position: Q1 2023 in Review

Storebrand Asset Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 6,738 shares — an estimated $69.3K sold.

Storebrand Asset Management first reported a position in NVAX in Q2 2021 and held it in 7 quarters. The position peaked at $6.12M in Q3 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Storebrand Asset Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Storebrand Asset Management sold 6,738 Novavax shares in Q1 2023, an estimated $69.3K.
  • Storebrand Asset Management first reported a position in Novavax in Q2 2021 and held it in 7 quarters.
  • Storebrand Asset Management's Novavax position peaked at $6.12M in Q3 2021.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Storebrand Asset Management's 13F filing for Q1 2023, filed 18 Jun 2026.